AWM Investment Company’s Opko Health OPK Stock Holding History

AWM Investment Company’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.39M	Hold	2,100,000	–	–	0.27%	74
2025 Q4	$2.65M	Sell	2,100,000 -100,000	-5%	-$139K	0.26%	82
2025 Q3	$3.41M	Buy	2,200,000 +200,000	+10%	+$275K	0.32%	74
2025 Q2	$2.64M	Buy	2,000,000 +150,000	+8%	+$205K	0.3%	76
2025 Q1	$3.07M	Buy	1,850,000 +550,000	+42%	+$906K	0.42%	61
2024 Q4	$1.91M	Hold	1,300,000	–	–	0.23%	67
2024 Q3	$1.94M	Hold	1,300,000	–	–	0.23%	71
2024 Q2	$1.63M	Hold	1,300,000	–	–	0.22%	71
2024 Q1	$1.56M	Buy	1,300,000 +200,000	+18%	+$200K	0.2%	79
2023 Q4	$1.66M	Buy	1,100,000 +100,000	+10%	+$145K	0.22%	80
2023 Q3	$1.6M	Hold	1,000,000	–	–	0.24%	75
2023 Q2	$2.17M	Hold	1,000,000	–	–	0.29%	66
2023 Q1	$1.46M	Hold	1,000,000	–	–	0.2%	81
2022 Q4	$1.25M	Buy	1,000,000 +200,000	+25%	+$315K	0.18%	79
2022 Q3	$1.51M	Hold	800,000	–	–	0.23%	78
2022 Q2	$2.02M	Hold	800,000	–	–	0.32%	69
2022 Q1	$2.75M	Hold	800,000	–	–	0.35%	69
2021 Q4	$3.85M	Hold	800,000	–	–	0.39%	65
2021 Q3	$2.92M	Hold	800,000	–	–	0.29%	80
2021 Q2	$3.24M	Hold	800,000	–	–	0.32%	76
2021 Q1	$3.43M	Hold	800,000	–	–	0.38%	71
2020 Q4	$3.16M	Hold	800,000	–	–	0.4%	64
2020 Q3	$2.95M	Hold	800,000	–	–	0.48%	58
2020 Q2	$2.73M	Buy	+800,000	New	+$1.79M	0.48%	55
2020 Q1	–	Sell	-1,000,000	Closed	-$1.47M	–	91
2019 Q4	$1.47M	Buy	1,000,000 +55,000	+6%	+$92.1K	0.29%	63
2019 Q3	$1.98M	Buy	945,000 +345,000	+58%	+$705K	0.42%	57
2019 Q2	$1.46M	Hold	600,000	–	–	0.28%	64
2019 Q1	$1.57M	Hold	600,000	–	–	0.31%	62
2018 Q4	$1.81M	Hold	600,000	–	–	0.39%	61
2018 Q3	$2.08M	Sell	600,000 -100,000	-14%	-$531K	0.34%	69
2018 Q2	$3.29M	Buy	700,000 +445,000	+175%	+$1.69M	0.55%	57
2018 Q1	$808K	Hold	255,000	–	–	0.16%	82
2017 Q4	$1.25M	Hold	255,000	–	–	0.24%	79
2017 Q3	$1.75M	Sell	255,000 -95,000	-27%	-$599K	0.31%	68
2017 Q2	$2.3M	Hold	350,000	–	–	0.41%	57
2017 Q1	$2.8M	Hold	350,000	–	–	0.52%	52
2016 Q4	$3.25M	Hold	350,000	–	–	0.64%	51
2016 Q3	$3.71M	Hold	350,000	–	–	0.68%	45
2016 Q2	$3.27M	Hold	350,000	–	–	0.7%	46
2016 Q1	$3.64M	Hold	350,000	–	–	0.76%	42
2015 Q4	$3.52M	Hold	350,000	–	–	0.69%	41
2015 Q3	$2.94M	Hold	350,000	–	–	0.57%	51
2015 Q2	$5.63M	Hold	350,000	–	–	0.8%	44
2015 Q1	$4.96M	Hold	350,000	–	–	0.69%	54
2014 Q4	$3.5M	Buy	+350,000	New	+$3M	0.48%	64

Other funds holding OPK

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WCM

Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AWM Investment Company's OPK Position: Q1 2026 in Review

AWM Investment Company held its Opko Health (OPK) position steady in Q1 2026 at 2,100,000 shares worth $2.39M. The position accounts for 0.27% of the portfolio, ranked #74.

AWM Investment Company first reported a position in OPK in Q4 2014 and has held it in 45 quarters since. The position peaked at $5.63M in Q2 2015. 236 funds tracked by Wall St. Rank hold OPK as of Q1 2026.

AWM Investment Company held 2,100,000 shares of Opko Health worth $2.39M as of Q1 2026.
AWM Investment Company left its Opko Health share count unchanged in Q1 2026.
Opko Health made up 0.27% of AWM Investment Company's portfolio in Q1 2026, its #74 holding.
AWM Investment Company first reported a position in Opko Health in Q4 2014 and has held it in 45 quarters since.
AWM Investment Company's Opko Health position peaked at $5.63M in Q2 2015.
236 funds tracked by Wall St. Rank held Opko Health as of Q1 2026.

Based on AWM Investment Company's 13F filing for Q1 2026, filed 15 May 2026.